{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T06:43:44Z","timestamp":1782888224486,"version":"3.54.5"},"reference-count":37,"publisher":"Elsevier BV","issue":"7-8","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100009367","name":"Mansoura University","doi-asserted-by":"crossref","award":["05\u20132008"],"award-info":[{"award-number":["05\u20132008"]}],"id":[{"id":"10.13039\/501100009367","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.bbalip.2011.04.014","type":"journal-article","created":{"date-parts":[[2011,5,8]],"date-time":"2011-05-08T01:55:00Z","timestamp":1304819700000},"page":"460-467","source":"Crossref","is-referenced-by-count":23,"title":["Eicosapentaenoic acid ablates valproate-induced liver oxidative stress and cellular derangement without altering its clearance rate: Dynamic synergy and therapeutic utility"],"prefix":"10.1016","volume":"1811","author":[{"given":"A.M.","family":"El-Mowafy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.","family":"Abdel-Dayem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Abdel-Aziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.F.","family":"El-Azab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.A.","family":"Said","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbalip.2011.04.014_bb0005","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.phymed.2010.08.004","article-title":"Novel chemotherapeutic and renal protective effects for the green-tea (EGCG): role of oxidative stress and inflammatory-cytokine signaling","volume":"17","author":"El-Mowafy","year":"2010","journal-title":"Phytomedicine"},{"issue":"12","key":"10.1016\/j.bbalip.2011.04.014_bb0010","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s11745-004-1342-z","article-title":"n-3 Fatty acids, inflammation, and immunity relevance to postsurgical and critically ill patients","volume":"39","author":"Calder","year":"2004","journal-title":"Lipids"},{"issue":"5","key":"10.1016\/j.bbalip.2011.04.014_bb0015","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1093\/carcin\/bgg015","article-title":"Resveratrol activates adenylyl-cyclase in human breast-cancer cells: a novel, estrogen receptor-independent cytostatic mechanism","volume":"24","author":"El-Mowafy","year":"2003","journal-title":"Carcinogenesis"},{"issue":"7\u20138","key":"10.1016\/j.bbalip.2011.04.014_bb0020","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1177\/106002809302700702","article-title":"Drug-related hospital admissions","volume":"27","author":"Einarson","year":"1993","journal-title":"Ann. Pharmacother."},{"issue":"2","key":"10.1016\/j.bbalip.2011.04.014_bb0025","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1527-3458.2003.tb00249.x","article-title":"Valproate: past, present, and future","volume":"9","author":"Johannessen","year":"2003","journal-title":"CNS Drug Rev."},{"key":"10.1016\/j.bbalip.2011.04.014_bb0030","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.reaurg.2004.03.014","article-title":"Severe valproate poisoning","volume":"13","author":"Bedry","year":"2004","journal-title":"R\u00e9animation"},{"key":"10.1016\/j.bbalip.2011.04.014_bb0035","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/hep.1840020513","article-title":"Valproate-induced hepatic injury: analyses of 23 fatal cases","volume":"2","author":"Zimmerman","year":"1982","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.bbalip.2011.04.014_bb0040","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1093\/clinchem\/34.5.890","article-title":"Valproic acid and the liver","volume":"34","author":"Cotarlu","year":"1988","journal-title":"Clin. Chem."},{"key":"10.1016\/j.bbalip.2011.04.014_bb0045","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1055\/s-2007-973560","article-title":"Altered antioxidant enzyme activities in children with a serious adverse experience related to valproic acid therapy","volume":"29","author":"Graf","year":"1998","journal-title":"Neuropediatrics"},{"issue":"2","key":"10.1016\/j.bbalip.2011.04.014_bb0050","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/toxsci\/kfi184","article-title":"Valproic acid: time course of lipid peroxidation biomarkers, liver toxicity, and valproic acid metabolite levels in rats","volume":"86","author":"Tong","year":"2005","journal-title":"Toxicol. Sci."},{"issue":"7","key":"10.1016\/j.bbalip.2011.04.014_bb0055","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1081\/CLT-100102388","article-title":"Multicenter case series of valproic acid ingestion: serum concentrations and toxicity","volume":"38","author":"Spiller","year":"2000","journal-title":"J. Toxicol. Clin. Toxicol."},{"issue":"5","key":"10.1016\/j.bbalip.2011.04.014_bb0060","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1021\/tx00047a006","article-title":"Fluorinated analogues as mechanistic probes in valproic acid hepatotoxicity: hepatic microvesicular steatosis and glutathione status","volume":"8","author":"Tang","year":"1995","journal-title":"Chem. Res. Toxicol."},{"issue":"2","key":"10.1016\/j.bbalip.2011.04.014_bb0065","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1006\/phrs.1997.0134","article-title":"Biochemical basis of sodium valproate hepatotoxicity and renal tubular disorder","volume":"35","author":"Raza","year":"1997","journal-title":"Pharmacol. Res."},{"issue":"4","key":"10.1016\/j.bbalip.2011.04.014_bb0070","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/j.1552-4604.1984.tb01823.x","article-title":"Protection against sodium valproate injury in isolated hepatocytes by alpha-tocopherol and N, N\u2032-diphenyl-p-phenylenediamine","volume":"24","author":"Buchi","year":"1984","journal-title":"J. Clin. Pharmacol."},{"issue":"2","key":"10.1016\/j.bbalip.2011.04.014_bb0075","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/15563650902752376","article-title":"Carnitine in the treatment of valproic acid-induced toxicity","volume":"47","author":"Lheureux","year":"2009","journal-title":"Clin. Toxicol. (Phila.)"},{"key":"10.1016\/j.bbalip.2011.04.014_bb0080","first-page":"67","article-title":"Essential fatty acids in health and chronic diseases","volume":"56","author":"Simopoulos","year":"2003","journal-title":"Forum Nutr."},{"issue":"1","key":"10.1016\/j.bbalip.2011.04.014_bb0085","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1747-1028-4-6","article-title":"Chemopreventive and renal protective effects for docosahexaenoic acid (DHA) implications of CRP and lipid peroxides","volume":"4","author":"El-Mesery","year":"2009","journal-title":"Cell Div."},{"issue":"1\u20132","key":"10.1016\/j.bbalip.2011.04.014_bb0090","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.plefa.2008.07.002","article-title":"Eicosapentaenoic acid inhibits interleukin-6 production in interleukin-1beta-stimulated C6 glioma cells through peroxisome proliferator-activated receptor-gamma","volume":"79","author":"Kawashima","year":"2008","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"issue":"1","key":"10.1016\/j.bbalip.2011.04.014_bb0095","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/07315724.2010.10719817","article-title":"Effect of omega-3 fatty acids supplementation on depressive symptoms and on health-related quality of life in the treatment of elderly women with depression; a double-blind, placebo-controlled, randomized clinical trial","volume":"29","author":"Rondanelli","year":"2010","journal-title":"J. Am. Coll. Nutr."},{"issue":"3","key":"10.1016\/j.bbalip.2011.04.014_bb0100","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.jhep.2008.10.031","article-title":"Eicosapentaenoic acid ameliorates steatohepatitis and hepatocellular carcinoma in hepatocyte-specific Pten-deficient mice","volume":"50","author":"Ishii","year":"2009","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbalip.2011.04.014_bb0105","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.yebeh.2010.01.001","article-title":"Acute administration of docosahexaenoic acid increases resistance to pentylenetetrazole-induced seizures in rats","volume":"17","author":"Taha","year":"2010","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.bbalip.2011.04.014_bb0110","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1053\/jhep.2001.23505","article-title":"Drug-induced liver injury mechanisms and test systems","volume":"33","author":"Bissell","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.bbalip.2011.04.014_bb0115","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1055\/s-2001-12929","article-title":"Mitochondria in steatohepatitis","volume":"21","author":"Pessayre","year":"2001","journal-title":"Semin. Liver Dis."},{"issue":"5","key":"10.1016\/j.bbalip.2011.04.014_bb0120","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1600-0404.2008.01009.x","article-title":"Hepatotoxicity associated with antiepileptic drugs","volume":"118","author":"Bj\u00f6rnsson","year":"2008","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.bbalip.2011.04.014_bb0125","first-page":"349","article-title":"Drug-induced hepatotoxicity","author":"Lee","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbalip.2011.04.014_bb0130","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1079\/BJN2000220","article-title":"Susceptibility of LDL to oxidative modification in healthy volunteers supplemented with low doses of n-3 polyunsaturated fatty acids","volume":"85","author":"Higgins","year":"2001","journal-title":"Br. J. Nutr."},{"issue":"2","key":"10.1016\/j.bbalip.2011.04.014_bb0135","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jhep.2008.04.023","article-title":"Prevention of alcoholic fatty liver and mitochondrial dysfunction in the rat by long-chain polyunsaturated fatty acids","volume":"49","author":"Song","year":"2008","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.bbalip.2011.04.014_bb0140","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.atherosclerosis.2009.07.049","article-title":"Subgram daily supplementation with docosahexaenoic acid protects low-density lipoproteins from oxidation in healthy men","volume":"208","author":"Calzada","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbalip.2011.04.014_bb0145","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1002\/hep.21626","article-title":"Omega-3 fatty acids alleviate chemically induced acute hepatitis by suppression of cytokines","volume":"45","author":"Schmocker","year":"2007","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.bbalip.2011.04.014_bb0150","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0009-9120(01)00217-X","article-title":"CYP2E1-mediated modulation of valproic acid-induced hepatocytotoxicity","volume":"34","author":"Neuman","year":"2001","journal-title":"Clin. Biochem."},{"issue":"22","key":"10.1016\/j.bbalip.2011.04.014_bb0155","doi-asserted-by":"crossref","first-page":"12559","DOI":"10.1073\/pnas.93.22.12559","article-title":"Polyunsaturated fatty acids modulate sodium and calcium currents in CA1 neurons","volume":"93","author":"Vreugdenhil","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.bbalip.2011.04.014_bb0160","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/MCO.0b013e32802b7030","article-title":"Omega-3 fatty acids, pro-inflammatory signaling and neuroprotection","volume":"10","author":"Bazan","year":"2007","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"issue":"5","key":"10.1016\/j.bbalip.2011.04.014_bb0165","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1211\/jpp.58.5.0010","article-title":"Docosahexaenoic acid (DHA) inhibits saquinavir metabolism in-vitro and enhances its bioavailability in rats","volume":"58","author":"Hirunpanich","year":"2006","journal-title":"J. Pharm. Pharmacol."},{"issue":"2","key":"10.1016\/j.bbalip.2011.04.014_bb0170","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1124\/dmd.105.007088","article-title":"Demonstration of docosahexaenoic acid as a bioavailability enhancer for CYP3A substrates in vitro and in vivo evidence using cyclosporin in rats","volume":"34","author":"Hirunpanich","year":"2006","journal-title":"Drug Metab. Dispos."},{"issue":"11","key":"10.1016\/j.bbalip.2011.04.014_bb0175","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1007\/s11095-008-9681-5","article-title":"Investigation of the drug-drug interaction between alpha-lipoic acid and valproate via mitochondrial beta-oxidation","volume":"25","author":"Phua","year":"2008","journal-title":"Pharm. Res."},{"issue":"4","key":"10.1016\/j.bbalip.2011.04.014_bb0180","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/sj.clpt.6100324","article-title":"Pharmacokinetic and pharmacodynamic interaction of lorazepam and valproic acid in relation to UGT2B7 genetic polymorphism in healthy subjects","volume":"83","author":"Chung","year":"2008","journal-title":"Clin. Pharmacol. Ther."},{"issue":"2\u20133","key":"10.1016\/j.bbalip.2011.04.014_bb0185","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.phymed.2008.12.018","article-title":"Synergy research: approaching a new generation of phytopharmaceuticals","volume":"16","author":"Wagner","year":"2009","journal-title":"Phytomedicine"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388198111000667?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388198111000667?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,19]],"date-time":"2020-06-19T00:14:25Z","timestamp":1592525665000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1388198111000667"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":37,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S1388198111000667"],"URL":"https:\/\/doi.org\/10.1016\/j.bbalip.2011.04.014","relation":{},"ISSN":["1388-1981"],"issn-type":[{"value":"1388-1981","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}